|
|
Post by mango on May 19, 2020 10:20:47 GMT -5
What would you like to see addressed at this year's ASM?
For me, I would like to know what is happening with our COVID-19 program, in detail, since our entire pipeline has been halted to focus solely on it. I expect major progress is being made daily, and a huge update from Mike on Thursday morning.
Last thing we need is another bogus partnership like so many we have seen before.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 19, 2020 10:34:34 GMT -5
What would you like to see addressed at this year's ASM? For me, I would like to know what is happening with our COVID-19 program, in detail, since our entire pipeline has been halted to focus solely on it. I expect major progress is being made daily, and a huge update from Mike on Thursday morning. Last thing we need is another bogus partnership like so many we have seen before. Do you really think Mike is going to read questions that will make him look bad? He is going to CHERRY PICK THE HELL OUT OF THE QUESTIONS. I'm not expecting any great answers. |
|
|
|
Post by boca1girl on May 19, 2020 11:52:10 GMT -5
Hope shareholders will be able to ask live questions during the meeting but I doubt it. It would be too risky for management.
|
|
|
|
Post by mnkdfann on May 19, 2020 13:36:43 GMT -5
What would you like to see addressed at this year's ASM? For me, I would like to know what is happening with our COVID-19 program, in detail, since our entire pipeline has been halted to focus solely on it. I expect major progress is being made daily, and a huge update from Mike on Thursday morning. Last thing we need is another bogus partnership like so many we have seen before. I wouldn't expect much change from what Mike said just about two weeks ago, unless I am missing something (which could well be the case): seekingalpha.com/article/4343933-mannkind-corporations-mnkd-ceo-michael-castagna-on-q1-2020-results-earnings-call-transcriptIn terms of developing treatments for COVID-19, we evaluated four opportunities that I talked about recently. At this point, we decided not pursuing two of them one because it's likely an OTC product, that we won't be able to move forward in our current capacity or FDA regulations. And the second one is, because it would require probably 10 to 15 cartridges of inhalation powder, three to four times a day, which just is not a feasible solution.
There are two other products that we remain under investigation. I'll continue to watch the marketplace as this evolves and see whether or not we move these forward. As we said previously, we're not going to invest a lot of shareholder money on COVID-19. But we will seek outside partners and opportunities to fund opportunity – fund these opportunities we're happy to dedicate our personnel and our infrastructure around these.
I'm hopeful as the vaccine comes available that we could be one of the partners to make an inhalable vaccine, like we've seen with the flu. But yes, we still need to find the vaccine before we get too optimistic on anything like that. In addition, mostly, it's really important that we sustain our business on reducing activities, which reduces our spend here in Q2 and through the year. |
|
|
|
Post by goyocafe on May 19, 2020 14:15:16 GMT -5
So they’ve halted the pipeline, but aren’t going to invest a lot into Covid. Seems like he just found his scapegoat for not advancing the original pipeline in 2020.
|
|
|
|
Post by brotherm1 on May 19, 2020 14:22:33 GMT -5
“I'm hopeful as the vaccine comes available that we could be one of the partners to make an inhalable vaccine, like we've seen with the flu.”
Anyone know which companies currently have an approved inhalable vaccine for the flu?
|
|
|
|
Post by patten1962 on May 19, 2020 16:37:23 GMT -5
I would like to know what is happening in Brazil and potentially other Countries.
I was thinking Technosphere would be more of a treatment for Covid 19?
|
|
|
|
Post by awesomo on May 19, 2020 17:37:40 GMT -5
I would like to know what is happening in Brazil and potentially other Countries. I was thinking Technosphere would be more of a treatment for Covid 19? Would be nice to have some details because their last earnings call highlighted a big fat $0.00 for international Afrezza revenue. |
|
|
|
Post by agedhippie on May 19, 2020 19:46:36 GMT -5
I would like to know what is happening in Brazil and potentially other Countries. I was thinking Technosphere would be more of a treatment for Covid 19? BIOMM posted their last quarter results last week, but there was nothing I could see relating to Afrezza sale numbers. |
|
|
|
Post by goyocafe on May 19, 2020 20:17:31 GMT -5
I would like to know what is happening in Brazil and potentially other Countries. I was thinking Technosphere would be more of a treatment for Covid 19? BIOMM posted their last quarter results last week, but there was nothing I could see relating to Afrezza sale numbers. A new astronomical phenomenon was discovered today; the MNKD Nebula. Good luck figuring any sheet out once you enter its cloud of influence. |
|
|
|
Post by longliner on May 19, 2020 20:23:04 GMT -5
“I'm hopeful as the vaccine comes available that we could be one of the partners to make an inhalable vaccine, like we've seen with the flu.” Anyone know which companies currently have an approved inhalable vaccine for the flu? |
|
|
|
Post by patten1962 on May 20, 2020 17:19:36 GMT -5
Respiratory antibodies will only last a few months. This is why we need a flu shot every year. I don't see Technosphere as a Vaccine i see it used more for Covid Treatment.
|
|
|
|
Post by mytakeonit on May 20, 2020 17:28:28 GMT -5
I haven't taken a flu shot since the days of my USAF duties. I would black out for about 24 hours every time I took it. I asked the doc if I had to take it during my second year and he said that I could refuse it. So, end of story.
But, that's mytakeonit
|
|
|
|
Post by mango on May 20, 2020 17:38:27 GMT -5
Altimmune is making an intranasal COVID-19 vaccine. Single dose. They are currently conducting preclinical studies with the University of Alabama.
Single use nasal spray.
|
|
|
|
Post by whale1r1 on May 20, 2020 23:33:49 GMT -5
Couple of points
Why hasn’t Mannkind and receptor released a recreational cannabis product using techno sphere?
Board of directors - they need to be engaged and clearly that is questionable. Specifically they have relationships with the Mann foundation. As we all know Mann donated big bucks to John Hopkins yet MannKind sales reps are having time getting any appointments to see the doctors.
Partnership front - we have board members who have worked at several high profile biotech companies in a senior officer role, yet its apparent those relationships are not being leveraged since there have been a lack of partnerships with these companies.
Sale of stock - rose a our investor relations person thinks it ok to sel stock for “tax reasons”. I say it’s time the board do what it should have done a long time ago and clawback those options.
|
|
